🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this Phase 1 study is to evaluate the safety, tolera...
Status
Terminated
Location
University of California, San Francisco
Start Date
2015-08-27
Trial ID
NCT02428309
Treatments Being Tested
RAPA-501-ALS is an Intermediate-Size Expanded Access Trial of RAPA-501 auto...
Status
Temporarily Not Available
Location
Barrow Neurological Institute
Start Date
TBD
Trial ID
NCT06169176
Treatments Being Tested
To evaluate if hyper-fractionated TBI or TMLI followed by Treg/Tcon adoptiv...
Status
Unknown
Location
University of Perugia
Start Date
2014-02
Trial ID
NCT03977103
Treatments Being Tested
The immune system has offensive and defensive capacities. In bone marrow tr...
Status
Terminated
Location
Katholieke Universiteit Leuven
Start Date
2013-07
Trial ID
NCT01903473
Treatments Being Tested
The purpose of this study is to investigate the safety and therapeutic effe...
Status
Unknown
Location
Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University
Start Date
2016-10
Trial ID
NCT02932826
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of QEL...
Status
Active Not Recruiting
Location
H. Saint Luc
Start Date
2022-01-21
Trial ID
NCT05234190
Treatments Being Tested
This study is a randomized, placebo-controlled, phase 2a trial to study the...
Status
Active Not Recruiting
Location
Massachusetts General Hospital Neurological Clinical Research Institute
Start Date
2019-08-07
Trial ID
NCT04055623
The goal of this research study is to determine whether it is safe and prac...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-11
Trial ID
NCT03773328
Treatments Being Tested
Phase 1 Safety Run-in Study of 6 patients followed by Phase 1b Randomized, ...
Status
Active Not Recruiting
Location
Columbia University Irving Medical Center
Start Date
2023-04-03
Trial ID
NCT05695521
To assess the safety and tolerability of CK0804 as add-on therapy in partic...
Status
Recruiting
Location
UC Davis Health
Start Date
2022-12-27
Trial ID
NCT05423691
Treatments Being Tested